Health

CJ CheilJedang, and Emmyon, Inc. sign a Licensing Agreement to commercialize a dietary supplement with natural extracts for use in significant improvement of skeletal muscle mass and function in humans.

SEOUL, South Korea and ROCHESTER, Minn., Dec. 26, 2022 /PRNewswire/ -- CJ Food and Nutrition Tech (CJ FNT), a newly formed business unit of CJ CheilJedang, a South Korea based global food and nutrition company, and Emmyon, Inc., a privately-held biotechnology start-up company based inRochester, MN...

2022-12-26 21:00 2961

Hyphens Pharma licenses Winlevi® for all 10 ASEAN countries from Cosmo Pharmaceuticals

* Winlevi® is a first-in-class topical drug for the treatment of acne approved by U.S. FDA inAugust 2020. * It will reinforce our Proprietary Brand segment's dermatological franchise. SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- Hyphens Pharma International Limited (" Hyphens Pharma", or the "Comp...

2022-12-23 17:00 2000

PVmed Raises US $14 Million Series A Funding from Cherami, Philips, JHF, COCOCAPITAL, and Strategy Capital

Will Support Rapid Expansion of PVmed's AI Cancer Treatment Product Portfolio GUANGZHOU, China, Dec. 22, 2022 /PRNewswire/ -- Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered inGuangzhou, China, has secured US ...

2022-12-23 11:31 2300

Ubitus and Smart Surgery enable doctors to practice robotic surgery with VR streaming

TOKYO, Dec. 22, 2022 /PRNewswire/ -- Ubitus K.K. (hereinafter Ubitus), a world-leading metaverse solution provider, supports Smart Surgery Technology to roll out its VR driven surgery simulation application – Sim Surgery. Smart Surgery Technology successfully demonstrated this innovative product ...

2022-12-22 22:00 2666

FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial

Exploring Xanamem® and the "cortisol hypothesis" for more than 6 million Americans suffering from Alzheimer's Disease[1]  SYDNEY, Dec. 22, 2022 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) is pleased to announce receipt today of agreement from the US Food and Drug Administration (FDA) to...

2022-12-22 20:30 1924

IASO Bio Announces U.S. FDA Approval of Clinical Trial Application for BCMA CAR-T CT103A for Relapsed/Refractory Multiple Myeloma

SHANGHAI and NANJING, China and SAN JOSE, Calif., Dec. 22, 2022 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products,, today announced that the Investiga...

2022-12-22 16:38 2017

Nuevocor to Present at Biotech Showcase during JPM week and at Keystone Symposium on Heart Development and Disease

SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- Nuevocor , a pre-clinical stage cardiac gene therapy company, announced today that it will be presenting at the Biotech Showcase during JPM week, taking place inSan Francisco, CA, USA from January 9 to 11, 2023. Nuevocor will als...

2022-12-21 22:00 2270

Waterdrop Chief Actuary Hui Teng: Good Products and Services Are the Underlying Logic of High-quality Transformation for Health Insurance

BEIJING, Dec. 21, 2022 /PRNewswire/ -- At the recently held 2022 China Insurance and Aged Healthcare Forum,Hui Teng, Chief Actuary of Waterdrop Inc., was invited to give a speech titled Good Products and Services Are the Underlying Logic of High-quality Transformation for Health Insurance. He sha...

2022-12-21 21:30 3201

I Peace, Inc. honored in BioSpectrum Asia Excellence Award 2022 with "Special Recognition in Cell Therapy"

PALO ALTO, Calif., Dec. 21, 2022 /PRNewswire/ -- I Peace, Inc. ( https://www.ipeace.com ), has been awarded a "Special Recognition in Cell Therapy" during BioSpectrum Asia Excellence Award 2022 ceremony held inSingapore on December 2 ( https://www.biospectrumasia.com/news/...

2022-12-21 15:10 2007

QureBio Ltd. to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI Meetings

SHANGHAI, Dec. 20, 2022 /PRNewswire/ --  QureBio Ltd., a clinical-stage biopharmaceutical company focusing on development of bispecific antibodies and other engineeredBiopharmaceuticals for the treatment of cancer, inflammation, and other serious disorders, today announced that Phase Ⅰ Clinical D...

2022-12-21 10:30 2304

WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index

SHANGHAI, Dec. 20, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufacturing services that enables the global pharmaceutical and healthcare industry, today announced that it has been included in the 2022 Dow Jones Sustainability™ World Index (DJSI). This demonstrates th...

2022-12-21 08:00 2321

PENTAX Medical U.S. launches endoscope drying solution PlasmaTYPHOONdry

The technology is a patented solution for quickly drying flexible endoscopes MONTVALE, N.J., Dec. 20, 2022 /PRNewswire/ -- PENTAX Medical America has launched a new fast endoscope drying solution -the PlasmaTYPHOONdry. Designed to improve productivity and traceability, this system further advanc...

2022-12-21 06:16 1983

Edan Medical UK Pointed out the Trend of Healthcare Innovation on the Interview Broadcasted on Sky TV

NORTHAMPTON, England, Dec. 20, 2022 /PRNewswire/ -- Edan Medical UK , one of the subsidiaries of Edan Instruments Inc. (300206.SZ) - a healthcare company and medical device manufacturer, shared its insights of healthcare innovation through the documentary programme:The Ro...

2022-12-20 22:34 2164

PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT

NANJING, China, Dec. 20, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group (2096.HK) announced today that, XIANNUOXIN (SIM0417), an anti-SARS-CoV-2 drug candidate jointly developed by Simcere with Shanghai Institute ofMateria Medica (the "SIMM") and Wuhan Institute of Virology (the "WIV"), Chines...

2022-12-20 19:21 2058

Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries

SHANGHAI and MOSCOW, Dec. 20, 2022 /PRNewswire/ -- Mabwell Bioscience (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, today announced the company has entered into an licensing agreement with the Russian pharmaceutical company Binnopharm Group, for 9M...

2022-12-20 17:00 2229

Korea Ginseng Corp. enhances its reputation as a leading herbal dietary brand by revealing a new set of stocking stuffers

* To commemorate its 123rd anniversary, Korea Ginseng Corp. has launched a new set of Koreselect online products, available exclusively online. * This holiday season, give your loved ones the gift of CheongKwanJang! CERRITOS, Calif., Dec. 20, 2022 /PRNewswire/ -- To celebrate its 123rd annive...

2022-12-20 15:23 2057

Shen Peng Awarded Charitable Entrepreneur of For Good Awards 2022

BEIJING, Dec. 19, 2022 /PRNewswire/ -- The annual conference of For Good Awards of China Social Enterprise and Impact Investment Forum declared the winners of For Good Awards 2022. Mr.Peng Shen, Founder and CEO of Waterdrop, was awarded one of the Top 10 Charitable Entrepreneurs of For Good Award...

2022-12-19 22:00 2435

Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON

WUHAN, China and SAN DIEGO, Dec. 19, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurophth")today announced receiving the U.S. Food and Drug Administration (FDA) clearance of its investigational new drug (IND) application on the in-vivo gene replacement therapy NFS-02 (rAAV2-ND1), for the...

2022-12-19 21:00 1757

SeekIn Receives CE-IVD Mark Approval for PanCanSeek® Cancer Mutation Detection Kit

First-of-its-kind one-for-all cancer mutation detection test SHENZHEN, China, Dec. 19, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for PanCanSeek® Cancer Mutation Detection Kit...

2022-12-19 21:00 1554

GenFleet Therapeutics and Merck Enter into Trial Collaboration to Initiate Study Investigating Combination Therapy of GFH925 (KRAS G12C inhibitor) and ERBITUX® (cetuximab)

SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck to start a clinical study of...

2022-12-19 19:00 1461
1 ... 110111112113114115116 ... 273